1
Copper is a cofactor for many cellular enzymes and transporters 1 . It can be loaded onto secreted and endomembrane cuproproteins by translocation from the cytosol into membrane-bound organelles by ATP7A or ATP7B transporters, the genes for which are mutated in the copper imbalance syndromes Menkes disease and Wilson disease, respectively 2 . Endomembrane cuproproteins are thought to incorporate copper stably on transit through the transGolgi network, in which ATP7A accumulates 3 by dynamic cycling through early endocytic compartments 4 . Here we show that the pigment-cell-specific cuproenzyme tyrosinase acquires copper only transiently and inefficiently within the trans-Golgi network of mouse melanocytes. To catalyse melanin synthesis, tyrosinase is subsequently reloaded with copper within specialized organelles called melanosomes. Copper is supplied to melanosomes by ATP7A, a cohort of which localizes to melanosomes in a biogenesis of lysosome-related organelles complex-1 (BLOC-1)-dependent manner. These results indicate that cell-type-specific localization of a metal transporter is required to sustain metallation of an endomembrane cuproenzyme, providing a mechanism for exquisite spatial control of metalloenzyme activity. Moreover, because BLOC-1 subunits are mutated in subtypes of the genetic disease Hermansky-Pudlak syndrome, these results also show that defects in copper transporter localization contribute to hypopigmentation, and hence perhaps other systemic defects, in HermanskyPudlak syndrome.
Copper is essential for all cells, but is particularly important for vertebrate pigmentation as a cofactor for the enzyme tyrosinase 5 . Tyrosinase is expressed in epidermal melanocytes and ocular pigment cells, and catalyses the initial steps of melanin biosynthesis within melanosomes 6 . Mutations in either of two copper-binding sites in tyrosinase ablate enzymatic activity and result in oculocutaneous albinism 7 . Melanin synthesis is limited to melanosomes, but tyrosinase is thought to acquire copper within the trans-Golgi network (TGN) as it traverses the secretory pathway towards melanosomes, because copper-dependent tyrosinase enzyme activity is first detected in the TGN 8 and in nearby clathrin-coated vesicles 9 . Copper is supplied to tyrosinase by the transporter ATP7A 10 ; accordingly, ATP7A-deficient mice are severely hypopigmented 11, 12 . Hypopigmentation is a feature of Hermansky-Pudlak syndrome (HPS) 13 , a multisystem disorder of subcellular organelle formation. HPS and corresponding mouse models result from mutations in any of 15 genes, most of which encode subunits of cytoplasmic complexes that regulate membrane trafficking. Among them, mutations in components of the eight-subunit BLOC-1 cause the most severe hypopigmentation 14 and an almost complete absence of pigment in melanocytes 15 . Several melanosomal proteins, including tyrosinaserelated protein-1 (TYRP1), are notably missorted and excluded from melanosome precursors in BLOC-1-deficient (BLOC-1 2 ) cells 15 , but tyrosinase is only partially missorted such that a substantial cohort properly localizes to non-pigmented melanosome precursors 15 . We hypothesized that these organelles lack pigment because the tyrosinase within them is inactive, perhaps owing to lack of its essential cofactor, copper. We thus assessed copper transporter localization in melanocytes and its dependence on BLOC-1.
By immunofluorescence microscopy (IFM) analysis of wild-type pigmented mouse melanocyte cell lines, ATP7A was detected in the perinuclear area and in punctate structures characteristic of the TGN and endosomes as in most other cell types, but was also detected in ,98% of pigmented cells within mature melanosomes, apparent as 'doughnuts' filled with dark melanin (Fig. 1a) . These ATP7A-containing structures colocalized with pigment granules detected by bright field microscopy (Fig. 1a, inset ) and with the melanosome membrane protein TYRP1 (Fig. 1c, inset) . ATP7B was not detected in these cells by IFM (data not shown). The signal obtained with the anti-ATP7A antibody was specific, because it was diminished (in an average of 28%-39% of cells) on depletion of endogenous ATP7A after transduction with several different Atp7a-specific small interfering RNAs (siRNAs) or with short hairpin RNA (shRNA) expression constructs ( Fig. 1d and Supplementary Fig. 1 ). Moreover, the signal did not reflect nonspecific adherence to melanin, because many of the ATP7A-depleted, antibody-non-reactive cells retained pigment (probably synthesized before ATP7A depletion; Fig. 1d , e and Supplementary Fig. 1 ). Immunoelectron microscopy (IEM) analysis confirmed that ATP7A localizes not only to Golgi and TGN membranes (see later in manuscript) but also to the limiting and intralumenal membranes of pigmented melanosomes (Fig. 1f, g ). This intramelanosomal distribution resembled that of tyrosinase 16 . ATP7A localization to melanosomes was further verified by subcellular fractionation (see later), consistent with a proteomic analysis of melanosome-enriched subcellular fractions of human MNT-1 melanoma cells 17 . Together, these results establish that a cohort of ATP7A in wild-type pigmented melanocytes localizes to melanosomes.
Whereas a cohort of tyrosinase is present in non-pigmented melanosomes in BLOC-1 2 cells, other melanosome proteins, including TYRP1, are excluded from melanosomes and accumulate in vacuolar early endosomes 15 . Like TYRP1 (but not tyrosinase 15 ), ATP7A was excluded from melanosomes in these cells, because it did not colocalize appreciably with the melanosome precursor marker, PMEL17, using IFM ( Supplementary Fig. 3C ), and was not detected in fibrillar melanosomes using IEM (Fig. 2g and Supplementary Fig. 4a, b) . Instead, ATP7A localized predominantly to the perinuclear area and peripheral early endosomes in BLOC-1 2 melan-mu and melan-rp cells, as shown by extensive colocalization with the mislocalized TYRP1 using IFM ( Fig. 2a and Supplementary Fig. 2 ; in melan-mu, 39 6 11% of peripheral ATP7A puncta contained TYRP1 and 81 6 11% of TYRP1 puncta contained ATP7A; mean 6 -s.e.m.) and with the early endosomal markers EEA1 and syntaxin 13 (also known as syntaxin 12; Fig. 2b , c and Supplementary Fig. 3A, B) . IEM analyses confirmed that ATP7A in these cells localized primarily to Golgi membranes and secondarily to tubulovesicular and vacuolar endosomes-which also often contained TYRP1, internalized transferrin (TRF) and tyrosinase ( Fig. 2g-i End.
End.
End. b)-and to multivesicular late endosomes. BLOC-1 'rescue' by expression of the missing Muted or BLOS3 (also known as BLOC1S3) subunit in melan-mu or melan-rp cells, respectively, resulted in reduced ATP7A expression (Fig. 2k ) but nevertheless restored pigmentation and melanosome localization for both ATP7A and TYRP1. IFM showed that 25% 6 7% of peripheral ATP7A localized to TYRP1-containing rings in BLOC-1-rescued (BLOC-1 R ) melan-mu:MuHA cells, and IEM showed that ATP7A was detected in melanosomes, as well as in endosomes and Golgi (Fig. 2d-f and Supplementary Figs 2 and 4c-e) .
IFM and IEM analyses were confirmed by subcellular fractionation on sucrose step gradients, in which a cohort of ATP7A was detected together with TYRP1 in a high density, pigmented melanosome fraction from BLOC-1 R cells but not from BLOC-1 2 cells (Fig. 2j and Supplementary Fig. 4f ). In the latter, ATP7A was only detected in lowdensity fractions and cofractionated with the TRF receptor and mistargeted TYRP1 (Fig. 2j and Supplementary Fig. 4f) . Furthermore, the results of cross-linking and immunoprecipitation analyses from both BLOC-1 2 and BLOC-1 R cells show that a cohort of ATP7A associates with the BLOC-1-dependent cargo protein TYRP1, but not BLOC-1-independent cargoes LAMP1 or TRF receptor ( Supplementary Fig.  5a-c) . Although the interaction with TYRP1 is not required for ATP7A trafficking to melanosomes ( Supplementary Fig. 5d ), the results suggest that ATP7A and TYRP1 are in close proximity within a transport intermediate before BLOC-1 function. Together, the data establish that melanosomal localization of ATP7A requires BLOC-1. In contrast, adaptor protein 3 (AP-3) is dispensable for ATP7A trafficking to melanosomes, because a large cohort of ATP7A, like TYRP1 (ref. 15) , efficiently localized to pigmented melanosomes in AP3B1-deficient melan-pe cells derived from HPS type 2 model pearl mice ( Supplementary Fig. 2m-o) .
If ATP7A is required to supply copper to tyrosinase in melanosomes, then the cohort of tyrosinase in non-pigmented melanosomes of BLOC-1 2 cells might be inactive owing to a lack of copper resulting from the absence of ATP7A. Indeed, 3,4-dihydroxy-phenylalanine (DOPA) cytochemistry analyses showed that tyrosinase activity in BLOC-1 2 melan-mu cells was nearly as low as that in tyrosinasedeficient melan-c cells, as judged by the paucity of melanin deposits formed in the presence of the tyrosinase substrate L-DOPA relative to the negative control D-DOPA (Fig. 3a, b, g, h) . In contrast, L-DOPAinduced melanin deposits were clearly observed in BLOC-1 R melanmu:MuHA cells (Fig. 3c, d ) and AP3B1-deficient melan-pe cells (Fig. 3i, j) . The low tyrosinase activity in BLOC-1 2 cells did not result from tyrosinase instability because immunoblotting showed that tyrosinase protein levels were only modestly lower in BLOC-1 2 than in BLOC-1 R cells, and much higher than the residual unprocessed tyrosinase in melan-c cells (Fig. 3k) . Modest tyrosinase activity was detected in melan-rp cells (Fig. 3e, f) , which lack the BLOC-1 subunit BLOS3; this is consistent with the partial assembly of BLOC-1 in these cells 18 and the milder hypopigmentation of reduced pigmentation mice from which melan-rp cells are derived 18, 19 . Together, these results indicate that tyrosinase is largely inactive in BLOC-1 2 melanocytes. To determine whether tyrosinase in BLOC-1 2 melanocytes is inactive because it lacks copper, we tested whether the addition of copper to the post-fixation DOPA cytochemistry reaction restored activity. Indeed, L-DOPA-dependent melanin pigmentation was notably increased in BLOC-1 2 melan-mu cells by the addition of 20 mM copper sulphate (Fig. 4a-d) . Pigmentation of BLOC-1 R melanmu:MuHA cells also increased on copper addition, albeit not as notably ( Supplementary Fig. 6a-d) . To determine the subcellular location of tyrosinase activity in these cells, DOPA cytochemistry reactions were analysed by electron microscopy. As expected, L-DOPA-induced melanin deposits (indicating active tyrosinase) in BLOC-1 R melanocytes were observed in mature (stage III and IV) melanosomes (Fig. 4g,  h ) and in the TGN in both the absence and the presence of copper, although copper consistently increased the signal in the TGN (Fig. 4g,  h) ; a cohort (,26%-28%; Supplementary Fig. 7g ) of melanosomes remained unpigmented (Supplementary Fig. 7a, b) , consistent with the absence of tyrosinase from stage II melanosomes 16 . In contrast, without added copper, L-DOPA-induced melanin deposits were only observed in the TGN of BLOC-1 2 melan-mu cells and not in the striated melanosomes ( Fig. 4e and Supplementary Fig. 7c, e, g ). Addition of copper to the L-DOPA cytochemistry reaction resulted in further melanin deposition within most striated melanosomes in BLOC-1 2 cells (Fig. 4f and Supplementary Fig. 7d, f) ; the fraction of melanosomes containing pigment among these cells was comparable to that of wild-type cells (Supplementary Fig. 7g ). The pigmented organelles observed in the presence of copper probably correspond to slightly more electron-dense fibrillar organelles observed in the absence of copper (Supplementary Fig. 7c ) and that harbour both PMEL17 and tyrosinase 15 . Together, these data indicate that tyrosinase is initially activated in the TGN, where ATP7A accumulates in these cells ( Supplementary Fig. 4a-e) , but is inactive in the nonpigmented melanosomes specifically because of a lack of copper. Copper also stimulated tyrosinase activity in BLOC-1 2 cells within tubular and vacuolar endosomes ( Supplementary Fig. 7d, f) , to which a cohort of tyrosinase is mislocalized in these cells 15 . Despite the presence of 25%-50% of immunodetectable tyrosinase in early endosomes of wild-type melanocytes 15, 16 , very little enzyme activity was detected in endosomes of BLOC-1 R cells regardless of the addition of copper ( Supplementary Fig. 7a, b) . Because the TGN and tubular endosomes are intermediates in tyrosinase transport to melanosomes 16 , the data suggest that tyrosinase inefficiently binds copper ions in the TGN in vivo and loses its bound copper ions in endosomes en route to melanosomes.
Our studies show that tissue-specific localization of the copper transporter ATP7A to a lysosome-related organelle, the melanosome, is required to supply copper to sustain the activity of a resident metalloenzyme, tyrosinase. We confirm that tyrosinase is first loaded with copper in the TGN 8 , a normal trafficking intermediate en route to melanosomes. However, unlike for ceruloplasmin, which binds copper very stably 20 , the copper seems to be loaded onto tyrosinase inefficiently and is subsequently stripped-probably in endosomal intermediates that function in TGN-to-melanosome trafficking 16 and must be reloaded within mature melanosomes. This mechanism provides tight spatial control of tyrosinase activity to ensure that melanin is produced only in mature melanosomes and that endosomal transport intermediates and melanosome precursors are protected from toxic melanin intermediates generated by premature tyrosinase activity (the TGN might additionally lack the L-DOPA or tyrosine substrates). Similar spatial regulation of copper integration probably exists for other endomembrane metalloproteins such as peptidylglycine a-amidating monooxygenase 21 , and preliminary results (our unpublished data) suggest that copper release from tyrosinase can be regulated by extracellular cues to provide fine-tuning of cuproenzyme activity. How bound copper is destabilized within endosomes is not clear, but a contributing factor is probably the low pH of these compartments. Tyrosinase is inactive at acidic pH 22 , perhaps owing to protonation of copper-coordinating histidine residues within the copper-binding domain 23 , and even the addition of excess copper in vitro could not restore tyrosinase activity at a pH of 5 in BLOC-1 2 melanocytes (Supplementary Fig. 8 ). However, prolonged exposure to low pH does not seem to be sufficient to destabilize bound copper (data not shown), suggesting that extra factors participate. In contrast, melanosomes become more alkaline as they mature 24 , providing an environment conducive to the reactivation of tyrosinase on re-exposure to copper.
The localization of ATP7A to melanosomes requires BLOC-1, which facilitates tissue-specific transport of selected cargoes to melanosomes 15 and other lysosome-related organelles 13, [25] [26] [27] . This dependence in part explains the hypopigmentation of BLOC-1-deficient mice and human patients with HPS types 7 and 8. Mislocalization of metal transporters such as ATP7A or ATP7B might contribute to other cell type defects in HPS, including the loss of functional dense granules in platelets and of lamellar bodies in type II pneumocytes. Retinal pigment epithelial cells, which also harbour melanosomes and are hypopigmented in HPS, express both ATP7A and ATP7B 28 . Whether either or both transporters localize to melanosomes during the brief period of melanogenesis in these cells 29 remains to be tested. Notably, tyrosinase activity in BLOC-1 2 melanocytes could be restored by addition of copper in vitro ( Supplementary Fig. 7i ), but not by incubation of live cells in excess copper (data not shown). This suggests that alternative transporters on melanosomes either cannot substitute for ATP7A or are also mislocalized in BLOC-1 2 cells.
METHODS SUMMARY
For bright field and immunofluorescence microscopy, cells were fixed with 2%-4% formaldehyde, labelled with the indicated primary and Alexa Fluor-conjugated secondary antibodies and analysed on a DM IRBE microscope (Leica Microsystems) equipped with an Orca digital camera (Hamamatsu) using OpenLab software (Improvision). Images obtained from consecutive z-planes were processed using subtractive volume deconvoluton with Improvision OpenLab. DOPA cytochemistry was performed as described 30 and similarly analysed but without image deconvolution; all images were obtained at similar camera and illumination settings. Electron microscopy analyses of immunogoldlabelled ultrathin cryosections or of DOPA-treated cells, and immunoblotting of whole cell lysates, were performed as described 18, 19 . Melan-Ink4a cells were transfected with siRNAs using oligofectamine and either analysed two to three days later (Fig. 1) or transfected a second time on day 3 and analysed two days later (Supplementary Fig. 1 ). Subcellular fractionation of cells disrupted by Dounce homogenization was performed using sedimentation on sucrose step gradients.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Reagents. Chemicals were from Sigma-Aldrich except where noted. Tissue culture reagents and Oligofectamine were from Invitrogen. FuGENE 6, Hygromycin B and protease inhibitor cocktail were from Roche Diagnostics. Protein A conjugated to 10-and 15-nm gold particles (PAG10 and PAG15) was from Cell Microscopy Center. Antibodies. Monoclonal antibodies: TA99 to TYRP1 and 9E10 to myc were from American Type Culture Collection; 1D4B to mouse LAMP-1 was from Developmental Studies Hybridoma Bank; HMB-45 to PMEL17 was from Lab Vision; H68.4 to TRF receptor was from Zymed; and GTU88 to c-tubulin was from Sigma-Aldrich. Polyclonal rabbit antibodies: H-90 to TYRP1 (used for immunoblotting) was from Santa Cruz Biotechnology; anti-fluorescein isothiocyanate (FITC) was from Invitrogen; and anti-tyrosinase 18 and anti-ATP7A (used for IFM studies) 31 have been described. Goat anti-EEA1 was from Santa Cruz Biotechnology. To generate Menkes antibody, Menkes peptide, corresponding to the carboxy-terminal 21 amino acid of mouse ATP7A (accession number NM 009726; sequence, SEPDKHSLLVGDFREDDDTTL), was synthesized and used to produce polyclonal antisera in rabbits (Genemed Synthesis). Crude antisera were used for immunoblotting experiments. For IEM experiments, antisera were affinity purified using Menkes peptide coupled to SulfoLink coupling gel (Pierce) according to the manufacturer's instructions. DNA constructs and siRNAs. Human syntaxin 13 with an N-terminal mycepitope tag was amplified from I.M.A.G.E. clone 3851266 and subcloned into the BamHI and XhoI sites of pCDNA3.1(1) (Invitrogen). Atp7a shRNA constructs were generated by cloning oligodeoxyribonucleotide duplexes containing the target sequences into the BamHI-HindIII sites of pRS shRNA (OriGene Technologies). The following sequences were selected as targets: AAA TGGCATGACTTGTAATTC (Atp7a-1), AATCTATGGGTTTAGAAGTAG (Atp7a-2) and AAAGATCGATCAGCCAACCAC (Atp7a-3). All plasmid inserts were verified by DNA sequencing. siRNAs bearing identical target sequences were obtained from Qiagen Sciences, Inc. As a control, empty pRS shRNA plasmid or siRNA to human t-Golgin-1 (ref. 32) was used in shRNA or siRNA experiments, respectively. Cell culture, transgene expression and siRNA transduction. The following immortalized mouse melanocyte cell lines were used. Wild-type melan-a 33 and melan-Ink4a 32 from C57BL/6 mice, tyrosinase-deficient melan-c and TYRP1-deficient melan-b 33 , AP-3-deficient melan-pe 16 , BLOC-1-deficient melan-mu3 (melan-mu) and melan-rp2 (melan-rp) and rescued melan-mu:MuHA and melan-rp:BLOS3 (stably expressing their respective missing BLOC-1 subunit) 15 , have been described. BLOC-1-deficient (BLOC-1 2
